LaFleur & Godfrey LLC Acquires 18,650 Shares of Kenvue Inc. (NYSE:KVUE)

LaFleur & Godfrey LLC grew its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 29.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 81,300 shares of the company's stock after buying an additional 18,650 shares during the period. LaFleur & Godfrey LLC's holdings in Kenvue were worth $1,736,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Grove Bank & Trust grew its stake in Kenvue by 438.4% during the 4th quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock worth $25,000 after purchasing an additional 947 shares in the last quarter. Riverview Trust Co acquired a new stake in shares of Kenvue during the 3rd quarter valued at approximately $30,000. Fortitude Family Office LLC increased its holdings in Kenvue by 106.6% during the 4th quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock valued at $32,000 after acquiring an additional 777 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Kenvue in the 3rd quarter valued at about $35,000. Finally, Versant Capital Management Inc grew its holdings in Kenvue by 300.8% in the 4th quarter. Versant Capital Management Inc now owns 1,920 shares of the company's stock valued at $41,000 after buying an additional 1,441 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on KVUE shares. Piper Sandler raised shares of Kenvue from a "neutral" rating to an "overweight" rating and lifted their price target for the stock from $21.00 to $26.00 in a research note on Monday, January 6th. UBS Group reduced their target price on shares of Kenvue from $24.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday. Barclays decreased their price objective on Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a research report on Friday. Citigroup dropped their price target on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research note on Wednesday, January 15th. Finally, JPMorgan Chase & Co. boosted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $23.08.

Kenvue Trading Down 0.4 %

KVUE stock traded down $0.09 during midday trading on Monday, hitting $21.11. The stock had a trading volume of 11,266,973 shares, compared to its average volume of 8,612,558. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The company's 50-day moving average price is $22.42 and its 200 day moving average price is $21.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The firm has a market cap of $40.46 billion, a PE ratio of 38.37, a price-to-earnings-growth ratio of 1.99 and a beta of 1.46.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business's revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.31 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.89%. The ex-dividend date is Wednesday, February 12th. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.